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Background. Donor safety is a major concern in living-donor liver transplantation. However, partial 
grafts do not meet the functional demands of recipients and lead to small-for-size syndrome (SFSS). 
In a previous study, we showed that olprinone (OLP), a selective phosphodiesterase ІІІ inhibitor, 
upregulates endothelial nitric oxide synthase level in the liver and attenuates shear stress, sinusoidal 
endothelial cell injury, and hepatocyte apoptosis after excessive liver resection in a rat model. We 
aimed to examine whether OLP treatment has beneficial effects on SFSS in a rat model of partial 
liver transplantation (PLT).  
Materials and Methods. Experiments were performed in a rat model of 30% PLT. In the OLP group, 
an osmotic pump with OLP was inserted into the peritoneal cavity 48 h before liver graft sampling. 
Recipient rats were not treated with OLP. We examined the liver microstructure by electron 
microscopy and biochemical examination, and determined the 7-day survival of the recipients.  
Results. In the OLP group 1 h after PLT, the sinusoidal endothelial cells of the liver were well 
preserved and few vacuolar structures in hepatocytes were observed. The total serum bilirubin level 
1 week after PLT tended to be lower in the OLP group than in the controls, and the liver 
microstructures were also well preserved in the OLP group. The probability of survival in the OLP 
group (100%, 14/14 rats) was significantly higher than that in the control group (75%, 15/20 rats).  








Adult-to-adult living-donor liver transplantation (A-LDLT) has become an alternative to 
deceased-donor liver transplantation [1]. One of the advantages of A-LDLT is reduction in waiting 
time and dropouts. However, donor safety remains a major concern. With regard to donor operations, 
the overall complication rate was reported to be significantly higher in the right-lobe graft group 
than in the left-lobe graft group [2]. The use of minimal graft volume to reduce the perioperative risk 
for living donors has been discussed [3].  
However, partial grafts do not meet the functional demands of the recipient and lead to 
liver failure, which is referred to as small-for-size syndrome (SFSS) [3]. Liver blood flow per unit 
immediately increases after partial liver transplantation (PLT), and increased blood flow in the portal 
vein exerts shear stress, thereby affecting the liver [3, 4]. Excessive shear stress causes liver injuries 
such as hepatocyte apoptosis and necrosis and sinusoidal endothelial cell injury [4]. SFSS is 
characterized by postoperative liver failure from shear stress due to excessive portal flow to the liver 
[3, 5]. Various animal experiments have been performed to establish treatments for SFSS, including 
splenectomy [6], portosystemic shunt placement [7], ischemic preconditioning [8], and 
pharmacological modifications [9,10]. Splenectomy is performed to reduce portal pressure if the 




Olprinone (OLP) has been clinically administered to patients with heart failure and to 
those undergoing cardiac surgery. It is a selective phosphodiesterase (PDE) ІІІ inhibitor with 
combined positive inotropic and vasodilator properties that are mediated by the elevation of 
intracellular cyclic adenosine monophosphate (cAMP) levels in vascular smooth muscle cells and 
cardiomyocytes by the prevention of cAMP degradation [12]. Nitric oxide produced by endothelial 
nitric oxide synthase (eNOS) plays an important role in reducing sinusoidal constriction during the 
early phase [13]. The importance of eNOS in hepatic injury after cold/warm reperfusion in 
transplanted liver grafts has been investigated [14]. In a previous study, we showed that OLP 
treatment upregulates eNOS levels in the liver and attenuates shear stress after excessive liver 
resection in rats to protect against sinusoidal endothelial cell injury and hepatocyte apoptosis [15]. 
Furthermore, OLP has been reported to protect the liver against ischemia-reperfusion injury (IRI) 
through an increase in cAMP levels and cytokine production [16]. IRI is a major cause of primary 
non-function of liver graft after liver transplantation. Moreover, IRI reduces liver regeneration after 
hepatectomy [17]. Therefore, OLP may be effective in overcoming SFSS and extending the 
minimum limits of the graft/recipient weight ratio. 
The purpose of this study was to examine whether OLP preconditioning has a beneficial 
effect on SFSS in a rat model of PLT, with a particular focus on OLP’s potential hepatoprotective 




Materials and Methods 
Animals 
Inbred male Lewis rats (age, 9 to 10 weeks; body weight, 240–280 g; SLC, Sizuoka, Japan) 
were used in this study. The rats were housed in a standard animal laboratory with free access to 
water and chow. The animals were kept under constant environmental conditions, with a 12-h 
light-dark cycle. All animal experiments were approved by the Animal Research Committee of 
Kyoto University. All animals were cared for in accordance with the National Institutes of Health 
(NIH) Guidelines for the Care and Use of Laboratory Animals. 
 
Experimental Design and Surgical Procedure 
The experiment was conducted in 2 groups of rats: an OLP-treated group and a control 
group. In the OLP group, rats were given 0.6 µg/kg/min OLP (a kind gift from Eizai Pharmaceutical 
Co, Ltd, Japan) using an Alzet osmotic pump (Model 2001; Durect Corp., Cupertino, CA, USA) that 
was inserted into the peritoneal cavity under sevoflurane anesthesia (Abbott, Japan, Osaka, Japan) 48 
h before the donor liver was harvested. Alzet peritoneal pump placement was used to ensure the 
steady administration of continuous OLP. OLP was not administered to recipient rats in this study. 
In the control group, preconditioned was not performed. 
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In this study, we used a rat model of 30% PLT without arterial reconstruction using the cuff 
method as an SFSS model [18, 19]. After ligation of the middle and right Glisson’s sheath, the liver 
was perfused with 10 mL of lactated Ringer’s solution through the portal vein. The right and caudate 
lobes of the liver were selected to be grafted on the back table. The graft was stored in cold Ringer’s 
solution, and the cold ischemia time was 50 min. During liver transplantation, the portal vein was 
clamped for 20 min. There were no differences in the ischemia reperfusion time between the 2 
groups. After surgery, the rats were given food and water ad libitum. Donor operation was performed 
after intraperitoneal administration of 25 mg/kg pentobarbital, and recipient operation was 
performed under inhalation anesthesia with sevoflurane and ether. No immunosuppressive agent was 
administered to the recipient rats. 
 
Electron Microscopy 
We examined the morphology of endothelial cells and hepatocytes by using scanning 
electron microscopy (SEM) and transmission electron microscopy (TEM). Liver samples from both 
groups were collected 1 h after portal venous reperfusion. The samples were prepared for electron 
microscopy as described previously [15]. Furthermore, these samples were compared with 3 samples 
collected from each liver at 7 days after 30% PLT with and without OLP preconditioning and after 





Blood samples were collected from survivors 1 week after PLT. Serum samples were 
stored at -80°C for measuring serum aspartate aminotransferase (AST), alanine aminotransferase 
(ALT), total bilirubin (T-Bil), and hyaluronic acid (HA) levels. Measurements were carried out by 
Japan Clinical Laboratories, Inc. 
 
Survival Study 
A total of 14 rats in the OLP group and 20 rats in the control group were used for the 
survival study. The OLP group operations were performed after those of the control group. All PLTs 
were performed consecutively. Rats that lived for 7 days after PLT were considered survivors. 
 
Statistical Analysis 
Student’s t-test was used to detect differences in the means of continuous measurements. A 
P value of less than 0.05 indicated statistical significance. All tests were 2-tailed. Probability of 
survival was calculated using the Kaplan–Meier method and examined with the log-rank test. JMP 





(1) Microstructure of the liver was well preserved in the OLP group1 h after PLT 
In the control group, SEM performed 1 h after PLT showed that the architecture of the 
sieve plate arrangement was fused and enlarged (Figure 1A). TEM showed that the sinusoidal wall 
was disrupted, and that microvilli extending from the parenchymal cell surface were damaged 
(Figure 1B). Vacuolar structures were observed in the cytoplasm of hepatocytes in the control group. 
In contrast, the architecture of the sieve plate arrangement in the OLP group was well preserved, and 
a thin layer of fenestrated endothelium was covered with the space of Disse, which was filled with 
microvilli (Figure 1C). Few vacuolar structures were observed in the OLP group (Figure 1D). These 
results indicate that OLP preconditioning preserves the microstructure of sinusoidal endothelial cells 
and hepatocytes against shear stress and IRI in the early phase after reperfusion. 
 
(2) OLP treatment attenuated hepatocyte and sinusoidal endothelial cell injury 1 week after PLT 
We evaluated the liver microstructure 1 week after PLT. In the PLT rats without OLP 
treatment, severe vacuolar degeneration was observed in the liver and the structure of sinusoidal 
endothelial cells was disrupted (Figure 2A). In contrast, in the OLP group, SEM showed 
well-preserved architecture of the sieve plate arrangement. In addition, TEM showed that the space 
of Disse was filled with microvilli; furthermore, no obvious hepatocyte structural disorder could be 
observed (Figure 2B). In the total liver transplantation model, no vacuolar degeneration was 
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observed, and the structure of the sinusoidal endothelial cells was well preserved (Figure 2C). 
Therefore, the microstructure of the liver in the OLP group was well preserved 1 week after PLT, 
similar to that after total liver transplantation. 
We also estimated liver function by performing biochemical examination. Biloma was 
observed at the resected end of the graft liver, with the incidence being 30% (4/14) and 20% (3/20) 
in the OLP and control groups, respectively. Survivors with biloma were excluded from the 
biochemical examination. The average T-Bil levels of the control and OLP groups were 1.03 and 
0.63, respectively (P = 0.46). Although the serum T-Bil level tended to be higher in the control group, 
the average values for AST, ALT, and HA were similar in both groups (Figure 3).  
 
(3) Probability of survival was improved in the OLP group 
 The probability of survival in the OLP group (100%, 14/14 rats) was significantly higher 
than that in the control group (75%, 15/20 rats) (Figure 4; P = 0.0478). Postoperative bleeding and 
biloma were not observed in non-survivors. The cause of death was thought to be postoperative liver 
failure, although 3 of the 5 non-survivors also showed diffuse lung inflammation. 
 
Discussion 
 OLP is reported to have the potential to protect the intestine, kidney, and heart against IRI, 
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with liver being an exception. An anti-inflammatory effect and improvement of microcirculation 
through an increase in cAMP levels are considered to be the mechanisms underlying organ 
protection [20-22]. We previously reported that OLP preconditioning upregulated eNOS protein 
levels in the liver and attenuated sinusoidal endothelial cell injury due to excessive shear stress [15]. 
In this study, we demonstrated that the microstructure of sinusoidal endothelial cells from 
OLP-treated grafts can also be preserved well in the early phase after 30% PLT in rats. The 
significant changes in hepatic microcirculation after PLT were transient and occurred mainly in the 
acute phase after reperfusion [23]. Therefore, preservation of microstructures in the early phase 
would be expected to result in a significant improvement in the 7-day survival. In addition, vacuolar 
structures were observed in the control group, whereas little vacuolar degeneration was observed in 
the OLP group. The increase in vacuolar degeneration in the early phase of liver transplantation and 
the extent of vacuolation observed after warm ischemia has been correlated with primary 
non-function and degree of hepatocellular damage [24]. Therefore, OLP treatment can also reduce 
hepatocyte damage caused by cold/warm IRI. This protective effect of OLP is expected to lead to a 
survival benefit. 
The control of the early mechanical injury caused by excessive shear stress and cold/warm 
reperfusion may be a promising surgical strategy for SFSS. Several studies with animal models have 
shown that pharmacological modification to reduce portal pressure can have a protective effect on 
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the liver in SFSS [9, 10, 25]. However, few pharmacological agents have actually been used in 
clinical practice. OLP has been clinically administered to patients with heart failure and to those 
undergoing cardiac surgery. OLP can be administered to patients undergoing liver surgery for liver 
protection more easily than other agents that are not clinically applicable. However, clinical trials are 
required to examine safety and efficacy and to establish an effective regimen to administer 
pharmacological agents with therapeutic potential. Therefore, we are performing a prospective trial 
to determine the safety of perioperative OLP administration for liver resection (UMIN000004975). 
OLP preconditioning was shown to have a protective effect on the microstructure of the 
liver in the early phase after PLT and improve survival in a rat model of SFSS. Furthermore, the 
protective effect of OLP on the microstructure of the liver was observed 1 week after PLT. Thus, 
OLP has therapeutic potential to overcome SFSS. 
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Figure 1. Scanning electron microscopy (SEM) micrographs (×8000) (A, C) and transmission 
electron microscopy (TEM) micrographs (B, D) of hepatic sinusoids obtained 1 h after partial liver 
transplantation (PLT). (A) In the control group, fenestrae were fused and enlarged, and sinusoidal 
endothelial cells were disrupted. Hepatocellular microvilli were partly exposed to the sinusoid lumen 
through the fenestrae. (B) In the control group, endothelial cells and hepatocellular microvilli were 
disrupted. Vacuolar structures were observed in the hepatocytes. Arrows indicate the vacuolar 
structures. (C) In the OLP group, fenestrae and sinusoidal cells were well preserved. (D) In the OLP 
group, endothelial cells were well preserved, whereas hepatocellular microvilli were slightly 
damaged. No vacuolar structures were observed. 
 
Figure 2. Liver microstructure 1 week after 30% partial liver transplantation (PLT) (A), after PLT 
treated with olprinone (B), and after total liver transplantation (C). 
 
Figure 3. Serum levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT), total 
bilirubin (T-Bil), and hyaluronic acid (HA) determined 1 week after partial liver transplantation.  
 
Figure 4. Kaplan–Meier curves of the control (n = 20) and olprinone (OLP; n = 14) groups. 




